Niger has been a recipient country of the Global Fund since 2004 and has been disbursed over US$442.1 million for HIV, TB and malaria.
As reported in the Audit Report; Global Fund Grants in the Republic of Niger released in September 2018, despite a challenging operating environment, Niger has made significant progress against the three diseases. The supply chain is able to distribute medicines, but fundamental gaps in the quantification, forecasting and stock monitoring processes still result in disruption of services. However. Niger is among a handful of countries in West and Central Africa to have nationwide seasonal transmission of malaria, which puts children under 5 at higher risk of contracting malaria during the peak transmission season. The Global Fund and partners’ investments help cover over 4 million children under 5 annually with seasonal malaria prophylaxis drugs, protecting them against the dangers of a malaria infection.
Niger pledged US$1 million for the Global Fund’s Sixth Replenishment, covering 2020-2022. The country is both a donor to the Global Fund and an implementer of Global Fund-supported programs.
About the action
The action in Niger is led by Éducation, Santé et Amélioration du Cadre de Vie (ESCAVI) with the support of the following partners.